Astaxanthin Market size worth $ 92.81 Billion, Globally, by 2031 at 2.38% CAGR – Report By Verified Market Research®
April 16, 2024 10:15 ET
|
Verified Market Research
Jersey City, New Jersey, April 16, 2024 (GLOBE NEWSWIRE) -- The Global Astaxanthin Market is projected to grow at a CAGR of 2.38% from 2024 to 2031, according to a new report published by Verified...
Asia Pharmaceutical Directory 2024: Top Source of Information on 10,000 Pharmaceutical and Biotechnology Companies
April 15, 2024 11:19 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Asian Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.Keep up-to-date with the Asian Pharmaceutical...
Global Pharma Handbook 2024: Expanded Coverage of Health Systems, Sales, Demand Profiles, Clinical Trials, Drug Approval Procedures, Regulatory Policies, IP, Pricing, Marketing, Generics
April 15, 2024 09:06 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Global Pharma Handbook 2024" directory has been added to ResearchAndMarkets.com's offering.The Global Pharma Handbook includes expanded coverage of...
European and USA Pharmaceutical Directory 2024: Indispensable Guide for Key Decision-makers
April 15, 2024 09:04 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "European and USA Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.The European & USA Pharmaceutical...
Global Directory Unveils Top 1,000 Pharmaceutical and Biotechnology Companies for 2024
April 15, 2024 09:02 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Major Pharmaceutical Companies 2024" report has been added to ResearchAndMarkets.com's offering. In an era of rapid technological advancements and...
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
April 15, 2024 08:00 ET
|
Optimi Health Corp.
Optimi announces completion of three batches of its MDMA API manufactured from raw materials under the Company’s Precursor Licence.
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mars 2024
April 12, 2024 14:05 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - March 2024
April 12, 2024 14:05 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Dalrada Financial Corporation Files Patent Application for Proprietary Technology that Creates Carbon Utility Tokens
April 10, 2024 08:45 ET
|
Dalrada Financial Corp.
DFCO stakes its claim in the carbon market with unique software/hardware system that creates a solution for generating, validating, trading carbon tokens
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
April 09, 2024 07:00 ET
|
Agios Pharmaceuticals, Inc.
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report